Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7876
First Trust Mid Cap Core AlphaDEX Fund
FNX
$1.41B
| $673K | ﹤0.01% |
8,041
-9,301
| -54% | -$855K |
|
7877
State Street SPDR S&P Capital Markets ETF
KCE
$473M
| $673K | ﹤0.01% |
9,226
-6,710
| -42% | -$537K |
|
7878
Quantum-Si Incorporated
QSI
$159M
| $673K | ﹤0.01% |
290,145
+248,460
| +596% | +$952K |
|
7879
PUT
Workiva
WK
$3.9B
| $673K | ﹤0.01% |
10,200
-1,100
| -10% | -$91.6K |
|
|
NVEI
7880
CALL
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $673K | ﹤0.01% |
18,600
-17,400
| -48% | -$907K |
|
|
CPUH
7881
PUT
DELISTED
Compute Health Acquisition Corp.
CPUH
| $673K | ﹤0.01% |
68,600
-128,200
| -65% | -$1.26M |
|
7882
CALL
Criteo S.A.
CRTO
$898M
| $671K | ﹤0.01% |
27,500
+1,400
| +5% | +$35.6K |
|
7883
CALL
Excelerate Energy
EE
$1.17B
| $671K | ﹤0.01% |
+33,700
| New | +$855K |
|
7884
PUT
ICL Group
ICL
$7B
| $671K | ﹤0.01% |
73,900
+7,000
| +10% | +$77.4K |
|
7885
PUT
Innospec
IOSP
$2.3B
| $671K | ﹤0.01% |
+7,000
| New | +$680K |
|
7886
Pegasystems
PEGA
$5.37B
| $671K | ﹤0.01% |
28,040
-360,210
| -93% | -$10.8M |
|
|
PHX
7887
DELISTED
PHX Minerals
PHX
| $671K | ﹤0.01% |
220,885
+207,648
| +1,569% | +$728K |
|
7888
Invesco NASDAQ Internet ETF
PNQI
$534M
| $671K | ﹤0.01% |
28,065
-12,910
| -32% | -$353K |
|
7889
CALL
Equinox Gold
EQX
$13.4B
| $670K | ﹤0.01% |
150,800
+34,300
| +29% | +$222K |
|
7890
PUT
Lightwave Logic
LWLG
$1.04B
| $670K | ﹤0.01% |
102,400
-96,800
| -49% | -$841K |
|
|
SILK
7891
PUT
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $670K | ﹤0.01% |
18,400
+12,200
| +197% | +$443K |
|
|
TWOU
7892
DELISTED
2U Inc
TWOU
| $670K | ﹤0.01% |
2,133
-1,487
| -41% | -$459K |
|
|
ARGO
7893
DELISTED
Argo Group International Holdings, Ltd.
ARGO
| $670K | ﹤0.01% |
18,191
-22,612
| -55% | -$929K |
|
7894
CALL
Banco Macro
BMA
$4.9B
| $669K | ﹤0.01% |
59,700
-27,400
| -31% | -$407K |
|
7895
Universal Corp
UVV
$1.12B
| $669K | ﹤0.01% |
+11,065
| New | +$660K |
|
|
GPP
7896
PUT
DELISTED
Green Plains Partners LP
GPP
| $669K | ﹤0.01% |
54,900
-27,300
| -33% | -$358K |
|
7897
CALL
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$148M
| $668K | ﹤0.01% |
17,200
+6,300
| +58% | +$221K |
|
7898
Northern Oil and Gas
NOG
$2.72B
| $668K | ﹤0.01% |
26,449
-37,981
| -59% | -$1.1M |
|
|
CONX
7899
DELISTED
CONX Corp. Class A Common Stock
CONX
| $668K | ﹤0.01% |
67,647
-1,980,053
| -97% | -$19.6M |
|
7900
PUT
Eversource Energy
ES
$27.3B
| $667K | ﹤0.01% |
7,900
+3,800
| +93% | +$338K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.